Pharma Industry News

information-analysis-insights

  • Home
  • Directories
  • Reports
  • Know Us
  • News
    • New Projects
    • New Launches
    • Formulations
    • Insights
    • New Drugs
    • BioTechnology
    • Ayurvedic Drugs

Cadila

Cadila Healthcare receives USFDA approval for Haloperidol Decanoate injection

November 10, 2019 IbisResearch 0

Cadila Healthcare has received USFDA approval for Haloperidol Decanoate injection used in treatment of schizophrenia. It is also used in the treatment of schizophrenia and […]

Cadila group receives USFDA approval for Ranolazine Extended-Release

August 30, 2019 IbisResearch 0

Zydus Cadila has received final USFDA approval to market generic Ranolazine Extended-Release tablets used for treatment of chronic angina in US markets. The company will […]

Cadila Pharma receives GLPC certification for its Dholka facility

June 20, 2019 IbisResearch 0

Cadila Pharma has received the Good Laboratory Practices Certification (GLP) from National Good Laboratory Practice compliance Monitoring Authority (NGCMA), Department of Science and Technology, Government […]

Cadial receives USFDA approval for Chlorthalidone

May 15, 2019 IbisResearch 0

Zydus Cadila has received final USFDA to market Chlorthalidone tablets, used to treat high blood pressure. The drug will be marketed in the strengths of […]

Cadila receives USFDA approval for Ambrisentan

April 1, 2019 IbisResearch 0

Zydus Cadila has received final USFDA approval to market Ambrisentan tablets in in strengths of 5 mg and 10 mg in the American market. The […]

Cadila receives USFDA approval for potassium chloride extended release tablets

March 15, 2019 IbisResearch 0

Cadila has received USFDA approval for Potassium Chloride extended-release capsules to market the same in United States. The product is used to treat or prevent […]

Cadila receives USFDA approval for Acetazolamide ER

January 27, 2019 IbisResearch 0

Zydus Cadila has received the final USFDA approval to market Acetazolamide ER Capsules. Acetazolamide is a potent carbonic anhydrase inhibitor. Acetazolamide ER capsules are used […]

Cadila receives USFDA approval for Aripiprazole

January 8, 2019 IbisResearch 0

Cadila has received final USFDA approval to market antipsychotic drug Aripiprazole tablets in US markets. The drug will be marketed in the strengths of 2 […]

Cadila Group has received USFDA approval for Doxycycline Hyclate and Febuxostat

December 31, 2018 IbisResearch 0

Zydus Cadila has received final USFDA approval to market Doxycycline Hyclate delayed-release tablets which are used to treat bacterial infections. The drug will be marketed […]

Zydus Cadila receives USFDA approval for Lansoprazole

December 22, 2018 IbisResearch 0

Zydus Cadila has received final USFDA approval to market generic Lansoprazole delayed release orally disintegrating tablets in the strengths of 15 mg and 30 mg. […]

Posts pagination

1 2 … 4 »

Segments

Ayurvedic Drugs
BioTechnology
Bulk Drugs
CRAMS
Formulations

India Pharma Directory

Recent Posts

  • CAR-T cell therapy gets commercial approval
  • New Research Centre to be developed in Lavale
  • Maharashtra government plans new bulk drug park in Raigad
  • Karnataka government plans new Bio Technology park near Bengaluru
  • Union Government incentives local API production

Search

About

Ibis Research-which maintains this site - aims to tracks core industrial sectors. It records Indian Pharmaceutical sector news, updates, technology trends, company profiles, updates address directories, tracks new project investments, posting updates on the latest development.

It provides timely information, analysis and insights.

This website tracks state government policies, employment opportunities in the sector, industry climate and economy forecast etc.,

New Projects
  • Maharashtra government plans new bulk drug park in Raigad

    November 21, 2020 0
  • Karnataka government plans new Bio Technology park near Bengaluru

    August 1, 2020 0
  • Desano Pharmaceuticals plans new manufacturing facility in Harohalli

    November 29, 2019 0
  • Union Government to develop a bulk drug park in Himachal Pradesh

    November 26, 2019 0
  • Suven Life Science plans expansion programme

    September 22, 2019 0
Latest News
  • CAR-T cell therapy gets commercial approval
  • New Research Centre to be developed in Lavale
  • Maharashtra government plans new bulk drug park in Raigad
  • Karnataka government plans new Bio Technology park near Bengaluru
  • Union Government incentives local API production

Copyright © 2025 | WordPress Theme by MH Themes